NNLX - NanoLogix, Incorporated Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNLX - NanoLogix, Incorporated

NNLX 0.0001000

0.0%

Oct 20 10:06 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: kphone	12/20/2011 2:19:13 PM
	Read Replies (2) of 78

Nanologix (NNLX) preparing for submittal to FDACOMPANY UPDATES December 19, 2011: NanoLogix Instructs Battelle to Prepare US FDA Submittals NanoLogix has instructed Battelle BioMedical Research Center to prepare the following for submittal to the US FDA, for a total of six separate applications. 1) Results of Battelle TB tests for approval for use as a BSL-3 test process for Tuberculosis using NanoLogix BNP technology 2) Results of the University of Texas Health Science Center-Houston Group B Streptoccocus tests (currently ongoing) for use as a recognized test kit using NanoLogix BNF technology 3) Results of multiple tests performed by Battelle on gram-positive bacteria with BNP and BNF technologies for approval as recognized tests for the gram-positive family of bacteria 4) Results of multiple tests performed by Battelle on gram-negative bacteria with BNP and BNF technologies for approval as recognized tests for the gram-negative family of bacteria All tests and data collection have been performed by independent third-party laboratories and will be submitted to the US FDA by third parties. As such, NanoLogix does not control the timeline for the submission process.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next